Jinling Pharmaceutical Company Limited (SHE:000919)
China · Delayed Price · Currency is CNY 8.58
-0.33 (-3.70%)
Apr 9, 2026, 3:04 PM CST
SHE:000919 Revenue
In the year 2025, Jinling Pharmaceutical Company had annual revenue of 3.20B CNY, down -2.56%. Jinling Pharmaceutical Company had revenue of 817.18M in the quarter ending December 31, 2025, with 8.83% growth.
Revenue
3.20B
Revenue Growth
-2.56%
P/S Ratio
1.67
Revenue / Employee
552.31K
Employees
5,789
Market Cap
5.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.20B | -84.13M | -2.56% |
| Dec 31, 2024 | 3.28B | 87.45M | 2.74% |
| Dec 31, 2023 | 3.19B | 523.03M | 19.58% |
| Jan 1, 2023 | 2.67B | -137.79M | -4.91% |
| Jan 1, 2022 | 2.81B | 305.02M | 12.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinhe Biotechnology CO., LTD. | 2.75B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Hunan Fangsheng Pharmaceutical | 1.68B |
| Tibet Weixinkang Medicine | 1.17B |
| LanZhou Foci Pharmaceutical | 895.75M |
| Newland Pharmaceutical | 672.38M |